person · Reporting owner

LIPPS RANDALL A

Disclosed activity across 2 companies

Tapewire entity: 22500
SEC CIK: 0001227556

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
OMNICELL, INC.OMCL · Entity 4666	Director · CHAIRMAN, CEO	August 15, 2026	August 18, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

OMNICELL, INC.

Report date August 15, 2026 · Filed August 18, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	511,095.7173	Reported balance After 2026-08-15 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-08-15 · Tax withholding · Disposed 12,350 · Balance 511,095.7173 F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. F2: The balance is adjusted to reflect 261.6432 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/26.
Common StockSEC Table I · non-derivative	IndirectIn Trust with Wife	345,861	Reported balance Holding disclosure · report date 2026-08-15 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 345,861 F3: Shares held in trust with Mr. Lipps' wife.
Common StockSEC Table I · non-derivative	IndirectIn Trust for Children	8,051	Reported balance Holding disclosure · report date 2026-08-15 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 8,051 F4: Shares held in trust for the benefit of Mr. Lipps' children.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

F2: The balance is adjusted to reflect 261.6432 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/26.

F3: Shares held in trust with Mr. Lipps' wife.

F4: Shares held in trust for the benefit of Mr. Lipps' children.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Invuity, Inc.

Report date October 23, 2018 · Filed October 23, 2018

Section 16 reporting ended · disclosed 2018-10-23. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Ending reported balance After 2018-10-23 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2018-10-23 · Disposition to issuer · Disposed 63,452 · Balance 52,231 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). Row 2 · 2018-10-23 · Disposition to issuer · Disposed 52,231 · Balance 0 F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price.
Common StockSEC Table I · non-derivative	IndirectSee footnote	Reported balance After 2018-10-23 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2018-10-23 · Disposition to issuer · Disposed 7,722 · Balance 0 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). F4: The shares are held by Lipps Family Ventures, of which the Reporting Person is a Manager.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.15 · Expires 2024-07-26	Direct	Reported balance After 2018-10-23 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2018-10-23 · Disposition to issuer · Disposed 2,054 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.87 · Expires 2021-05-19	Direct	Reported balance After 2018-10-23 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2018-10-23 · Disposition to issuer · Disposed 28,900 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price").

F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock.

F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price.

F4: The shares are held by Lipps Family Ventures, of which the Reporting Person is a Manager.

F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 25, 2019 Filed Oct 28, 2019 20:33 UTC	OMNICELL, INC. OMCL · Entity 4666	Exercise / conversionStock Options NQ (Right to Buy) · Derivative	1,172	$0.00 Strike: $27.70	$0.00	Disclosure SEC source: 0001179110-19-011249 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,172 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document
October 25, 2019 Filed Oct 28, 2019 20:33 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	1,172	$78.00	$91,416.00	Disclosure SEC source: 0001179110-19-011249 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,487 F4 · shares: The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4, the shares were all sold at an exact price of $78.00. Read SEC document
October 25, 2019 Filed Oct 28, 2019 20:33 UTC	OMNICELL, INC. OMCL · Entity 4666	Exercise / conversionCommon Stock	1,172	$0.00	$0.00	Disclosure SEC source: 0001179110-19-011249 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document
October 21, 2019 Filed Oct 21, 2019 23:01 UTC	OMNICELL, INC. OMCL · Entity 4666	Exercise / conversionStock Options NQ (Right to Buy) · Derivative	25,926	$0.00 Strike: $27.70	$0.00	Disclosure SEC source: 0001179110-19-011153 · edgar.xml · derivative · entry 9 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,926 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 21, 2019 Filed Oct 21, 2019 23:01 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	25,926	$78.03	$2,022,990.22	Disclosure SEC source: 0001179110-19-011153 · edgar.xml · nonDerivative · entry 8 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,487 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F7 · price: The price reported in Column 4 is the average price of $78.0294. The sold price range between $78.00 to $78.21. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
October 21, 2019 Filed Oct 21, 2019 23:01 UTC	OMNICELL, INC. OMCL · Entity 4666	Exercise / conversionCommon Stock	25,926	$0.00	$0.00	Disclosure SEC source: 0001179110-19-011153 · edgar.xml · nonDerivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan Read SEC document
October 18, 2019 Filed Oct 18, 2019 22:01 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	400	$76.87	$30,747.00	Disclosure SEC source: 0001179110-19-011130 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 289,409 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F6 · price: The price reported in Column 4 is the average price of $76.8675. The sold price range between $76.72 to $77.7199. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
October 18, 2019 Filed Oct 18, 2019 22:01 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	3,500	$76.22	$266,766.15	Disclosure SEC source: 0001179110-19-011130 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 289,809 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F5 · price: The price reported in Column 4 is the average price of $76.2189. The sold price range between $75.65 to $76.6499. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
October 18, 2019 Filed Oct 18, 2019 22:01 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	1,100	$75.17	$82,688.98	Disclosure SEC source: 0001179110-19-011130 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 293,309 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F4 · price: The price reported in Column 4 is the average price of $75.1718. The sold price range between $74.64 to $75.6399. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
October 18, 2019 Filed Oct 21, 2019 23:01 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	400	$76.87	$30,747.00	Disclosure SEC source: 0001179110-19-011153 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 289,409 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F6 · price: The price reported in Column 4 is the average price of $76.8675. The sold price range between $76.72 to $77.7199. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
October 18, 2019 Filed Oct 21, 2019 23:01 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	3,500	$76.22	$266,766.15	Disclosure SEC source: 0001179110-19-011153 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 289,809 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F5 · price: The price reported in Column 4 is the average price of $76.2189. The sold price range between $75.65 to $76.6499. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
October 18, 2019 Filed Oct 21, 2019 23:01 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	1,100	$75.17	$82,688.98	Disclosure SEC source: 0001179110-19-011153 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 293,309 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F4 · price: The price reported in Column 4 is the average price of $75.1718. The sold price range between $74.64 to $75.6399. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
July 25, 2019 Filed Jul 26, 2019 20:22 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	5,000	$70.30	$351,479.50	Disclosure SEC source: 0001179110-19-008842 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 294,409 F1 · shares: Shares held in trust with Mr. Lipps' wife. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F4 · price: The price reported in Column 4 is the average price of $70.2959. The sold price range between $70.01 to $70.58. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
June 15, 2019 Filed Jun 17, 2019 21:21 UTC	OMNICELL, INC. OMCL · Entity 4666	Tax withholdingCommon Stock	12,019	$81.03	$973,899.57	Disclosure SEC source: 0001179110-19-007780 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,487 F3 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document
May 29, 2019 Filed Jun 17, 2019 21:21 UTC	OMNICELL, INC. OMCL · Entity 4666	GiftCommon Stock	12,500	$0.00	$0.00	Disclosure SEC source: 0001179110-19-007780 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 299,409 F4 · shares: Gifted on 5/29/19 to Donor advised Fund from Family trust account. Read SEC document
April 29, 2019 Filed May 2, 2019 00:11 UTC	OMNICELL, INC. OMCL · Entity 4666	Exercise / conversionStock Options NQ (Right to Buy) · Derivative	11,000	$0.00 Strike: $27.70	$0.00	Disclosure SEC source: 0001179110-19-005372 · edgar.xml · derivative · entry 16 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,000 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
April 29, 2019 Filed May 2, 2019 00:11 UTC	OMNICELL, INC. OMCL · Entity 4666	Exercise / conversionStock Options NQ (Right to Buy) · Derivative	13,282	$0.00 Strike: $25.08	$0.00	Disclosure SEC source: 0001179110-19-005372 · edgar.xml · derivative · entry 15 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,282 shares Expires 2024-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
April 29, 2019 Filed May 2, 2019 00:11 UTC	OMNICELL, INC. OMCL · Entity 4666	OtherCommon Stock	36,296	$0.00	$0.00	Disclosure SEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 14 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 311,909 F12 · shares: Transfer from shares held directly by Mr. Lipps to shares held in trust with Mr. Lipps' wife. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document
April 29, 2019 Filed May 2, 2019 00:11 UTC	OMNICELL, INC. OMCL · Entity 4666	OtherCommon Stock	36,296	$0.00	$0.00	Disclosure SEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 13 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,506 F12 · shares: Transfer from shares held directly by Mr. Lipps to shares held in trust with Mr. Lipps' wife. Read SEC document
April 29, 2019 Filed May 2, 2019 00:11 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	5,000	$79.59	$397,970.00	Disclosure SEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 12 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 275,613 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F11 · price: The price reported in Column 4 is the average price of $79.5940. The sold price range between $76.89 to 81.39. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document
April 29, 2019 Filed May 2, 2019 00:11 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	11,000	$78.28	$861,114.10	Disclosure SEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 11 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,802 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F10 · price: The price reported in Column 4 is the average price of $78.2831. The sold price range between $78.00 to $79.04. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
April 29, 2019 Filed May 2, 2019 00:11 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	1,766	$79.62	$140,601.86	Disclosure SEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 10 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,802 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F9 · price: The price reported in Column 4 is the average price of $79.6160. The sold price range between $81.20 to $81.45. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
April 29, 2019 Filed May 2, 2019 00:11 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	3,407	$79.62	$271,251.71	Disclosure SEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 9 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,568 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F8 · price: The price reported in Column 4 is the average price of $79.6160. The sold price range between $80.18 to $81.18. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
April 29, 2019 Filed May 2, 2019 00:11 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	4,100	$79.62	$326,425.60	Disclosure SEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 8 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,975 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F7 · price: The price reported in Column 4 is the average price of $79.6160. The sold price range between $79.00 to $79.99. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
April 29, 2019 Filed May 2, 2019 00:11 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	2,600	$79.62	$207,001.60	Disclosure SEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,075 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F6 · price: The price reported in Column 4 is the average price of $79.6160. The sold price range between $77.96 to $78.9150. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
April 29, 2019 Filed May 2, 2019 00:11 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	1,409	$79.62	$112,178.94	Disclosure SEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,675 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · price: The price reported in Column 4 is the average price of $79.6160. The sold price range between $76.94 to $77.93. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
April 29, 2019 Filed May 2, 2019 00:11 UTC	OMNICELL, INC. OMCL · Entity 4666	Exercise / conversionCommon Stock	24,282	$0.00	$0.00	Disclosure SEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document
March 05, 2019 Filed Mar 7, 2019 00:29 UTC	OMNICELL, INC. OMCL · Entity 4666	Tax withholdingCommon Stock	6,270	$84.27	$528,372.90	Disclosure SEC source: 0001179110-19-003483 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,523 F3 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document
February 22, 2019 Filed Feb 22, 2019 23:18 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	6,046	$85.84	$518,998.31	Disclosure SEC source: 0001179110-19-002423 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,793 F5 · price: The price reported in Column 4 is the Average price of $85.8416. The share price were between $85.70 to $86.18. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 22, 2019 Filed Feb 22, 2019 23:18 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	13,954	$85.40	$1,191,702.30	Disclosure SEC source: 0001179110-19-002423 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,839 F4 · price: The price reported in Column 4 is the Average price of $85.4022. The share price were between $84.70 to $85.69. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 13, 2019 Filed Feb 16, 2019 00:49 UTC	OMNICELL, INC. OMCL · Entity 4666	GrantStock Option (Right to Buy) · Derivative	83,845	$0.00 Strike: $78.91	$0.00	Disclosure SEC source: 0001179110-19-002029 · edgar.xml · derivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,845 Underlying: Common Stock · 83,845 shares Expires 2029-02-12 F3 · shares: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document
February 13, 2019 Filed Feb 16, 2019 00:49 UTC	OMNICELL, INC. OMCL · Entity 4666	GrantCommon Stock	39,250	$0.00	$0.00	Disclosure SEC source: 0001179110-19-002029 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,793 F4 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2020 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2020 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance. Read SEC document
February 13, 2019 Filed Feb 22, 2019 23:18 UTC	OMNICELL, INC. OMCL · Entity 4666	GrantStock Option (Right to Buy) · Derivative	83,845	$0.00 Strike: $78.91	$0.00	Disclosure SEC source: 0001179110-19-002423 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,845 Underlying: Common Stock · 83,845 shares Expires 2029-02-12 F3 · shares: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document
December 18, 2018 Filed Dec 18, 2018 22:49 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	4,028	$64.35	$259,201.80	Disclosure SEC source: 0001179110-18-014083 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,543 F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4 is the average price of $64.35. The shares sold between $64.00 to $64.70. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
December 18, 2018 Filed Dec 18, 2018 22:49 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	5,454	$63.55	$346,601.70	Disclosure SEC source: 0001179110-18-014083 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,571 F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · price: The price reported in Column 4 is the average price of $63.55. The shares sold between $63.11 to $63.99. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
December 15, 2018 Filed Dec 17, 2018 22:45 UTC	OMNICELL, INC. OMCL · Entity 4666	Tax withholdingCommon Stock	2,864	$0.00	$0.00	Disclosure SEC source: 0001179110-18-013977 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,025 F3 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document
December 15, 2018 Filed Dec 17, 2018 22:45 UTC	OMNICELL, INC. OMCL · Entity 4666	Tax withholdingCommon Stock	8,376	$0.00	$0.00	Disclosure SEC source: 0001179110-18-013977 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,889 F3 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document
October 23, 2018 Filed Oct 23, 2018 21:39 UTC	Invuity, Inc. IVTY · Entity 162847	Disposition to issuerDirector Stock Option (right to buy) · Derivative	28,900	$0.00 Strike: $4.87	$0.00	Disclosure SEC source: 0001209191-18-055984 · doc4.xml · derivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,900 shares Expires 2021-05-19 F5 · derivative.exercise_date: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. Read SEC document
October 23, 2018 Filed Oct 23, 2018 21:39 UTC	Invuity, Inc. IVTY · Entity 162847	Disposition to issuerDirector Stock Option (right to buy) · Derivative	2,054	$0.00 Strike: $3.15	$0.00	Disclosure SEC source: 0001209191-18-055984 · doc4.xml · derivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,054 shares Expires 2024-07-26 F5 · derivative.exercise_date: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. Read SEC document
October 23, 2018 Filed Oct 23, 2018 21:39 UTC	Invuity, Inc. IVTY · Entity 162847	Disposition to issuerCommon Stock	7,722	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-18-055984 · doc4.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · price: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). F4 · ownership.nature: The shares are held by Lipps Family Ventures, of which the Reporting Person is a Manager. Read SEC document
October 23, 2018 Filed Oct 23, 2018 21:39 UTC	Invuity, Inc. IVTY · Entity 162847	Disposition to issuerCommon Stock	52,231	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-18-055984 · doc4.xml · nonDerivative · entry 2 LIPPS RANDALL A · CIK 0001227556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. F3 · price: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price. Read SEC document
October 23, 2018 Filed Oct 23, 2018 21:39 UTC	Invuity, Inc. IVTY · Entity 162847	Disposition to issuerCommon Stock	63,452	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-18-055984 · doc4.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,231 F1 · price: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). Read SEC document
June 19, 2018 Filed Jun 20, 2018 22:25 UTC	OMNICELL, INC. OMCL · Entity 4666	Exercise / conversionStock Options NQ (right to Buy) · Derivative	18,154	$0.00 Strike: $25.08	$0.00	Disclosure SEC source: 0001179110-18-008859 · edgar.xml · derivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,154 Underlying: Common Stock · 18,154 shares Expires 2025-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document
June 19, 2018 Filed Jun 20, 2018 22:25 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	18,154	$52.00	$944,008.00	Disclosure SEC source: 0001179110-18-008859 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,265 F3 · price: The price reported in Column 4 is the exact price of $52.00 the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
June 19, 2018 Filed Jun 20, 2018 22:25 UTC	OMNICELL, INC. OMCL · Entity 4666	Exercise / conversionCommon Stock	18,154	$0.00	$0.00	Disclosure SEC source: 0001179110-18-008859 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document
June 19, 2018 Filed Jun 20, 2018 22:25 UTC	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	9,483	$52.04	$493,502.91	Disclosure SEC source: 0001179110-18-008859 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,265 F5 · price: The price reported in Column 4 is the Average price of $52.0408. The shares sold between $51.35 to $52.25. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
June 19, 2018 Filed Aug 23, 2018 22:58 UTC Amendment	OMNICELL, INC. OMCL · Entity 4666	Exercise / conversionStock Options NQ (right to Buy) · Derivative	18,154	$0.00 Strike: $25.08	$0.00	Disclosure SEC source: 0001179110-18-010845 · edgar.xml · derivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,154 Underlying: Common Stock · 18,154 shares Expires 2025-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document
June 19, 2018 Filed Aug 23, 2018 22:58 UTC Amendment	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	18,154	$52.00	$944,008.00	Disclosure SEC source: 0001179110-18-010845 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,265 F3 · price: The price reported in Column 4 is the exact price of $52.00 the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
June 19, 2018 Filed Aug 23, 2018 22:58 UTC Amendment	OMNICELL, INC. OMCL · Entity 4666	Exercise / conversionCommon Stock	18,154	$0.00	$0.00	Disclosure SEC source: 0001179110-18-010845 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document
June 19, 2018 Filed Aug 23, 2018 22:58 UTC Amendment	OMNICELL, INC. OMCL · Entity 4666	SaleCommon Stock	9,483	$52.04	$493,502.91	Disclosure SEC source: 0001179110-18-010845 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,265 F5 · price: The price reported in Column 4 is the Average price of $52.0408. The shares sold between $51.35 to $52.25. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.